![Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression]()
Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regressionHebb, Jonathan P. O.; Mosley, Adriane R.; Vences-Catalán, Felipe; Rajasekaran, Narendiran; Rosén, Anna; Ellmark, Peter; Felsher, Dean W. · Cancer Immunology, Immunotherapy · 2017